GLENN JEFFREY S purchased 121.4% of their position (100K shares) of EIGER BIOPHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $128.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/27/2022ACC: 0001140361-22-047070
Director
Since Mar 2019
+100K
Net shares
Net buyer
$128.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+100K
Price / share
$1.28
Trade value
$127.95K
% of position
121.4%
12/22/2022
82.36K→182.35K
Total
Net shares
+100K
Net value
$127.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/22/2022 | P · Purchase | +100K | $1.28 | $127.95K | 121.4% | 82.36K | 182.35K |
| Total | +100K | $127.95K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned5K
Common Stock
IndirectShares owned151.06K
Common Stock
IndirectShares owned460.00
Total
156.52K indirect156.52K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5K | Indirect |
| Common Stock | 151.06K | Indirect |
| Common Stock | 460.00 | Indirect |
| Total | 156.52K | 156.52K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported